Scarica l'app Stockscreener
6.61
2.16%
0.14
Dopo l'orario di chiusura:
6.61
Precedente Chiudi:
$6.47
Aprire:
$6.52
Volume 24 ore:
646.71K
Relative Volume:
0.61
Capitalizzazione di mercato:
$308.70M
Reddito:
$20.72M
Utile/perdita netta:
$-100.84M
Rapporto P/E:
-2.485
EPS:
-2.66
Flusso di cassa netto:
$-78.56M
1 W Prestazione:
+6.96%
1M Prestazione:
+26.15%
6M Prestazione:
+66.50%
1 anno Prestazione:
-57.68%
Intervallo 1D:
$6.09
$6.65
Intervallo di 1 settimana:
$5.97
$6.65
Portata 52W:
$2.235
$17.41
4 D Molecular Therapeutics Inc Stock (FDMT) Company Profile
Nome
4 D Molecular Therapeutics Inc
Settore
Industria
Telefono
(510) 505-2680
Indirizzo
5858 HORTON STREET #455, EMERYVILLE
Confronta FDMT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FDMT
4 D Molecular Therapeutics Inc
|
6.61 | 286.75M | 20.72M | -100.84M | -78.56M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
4 D Molecular Therapeutics Inc Stock (FDMT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-13 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-11-21 | Iniziato | Morgan Stanley | Underweight |
| 2024-09-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-04-15 | Iniziato | Barclays | Overweight |
| 2024-02-07 | Ripresa | Goldman | Buy |
| 2023-10-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-18 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Chardan Capital Markets | Buy |
| 2023-01-30 | Iniziato | BMO Capital Markets | Outperform |
| 2022-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-11-15 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-12 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-06-22 | Iniziato | Jefferies | Buy |
| 2022-01-04 | Iniziato | SVB Leerink | Outperform |
| 2021-01-05 | Iniziato | BofA Securities | Buy |
| 2021-01-05 | Iniziato | Evercore ISI | Outperform |
| 2021-01-05 | Iniziato | Goldman | Neutral |
Mostra tutto
4 D Molecular Therapeutics Inc Borsa (FDMT) Ultime notizie
4D Molecular Therapeutics Inc. stock trendline breakdown2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
Chart based analysis of 4D Molecular Therapeutics Inc. trendsDollar Strength & Real-Time Buy Signal Alerts - Newser
Real time scanner hits for 4D Molecular Therapeutics Inc. explained2025 Price Action Summary & Long-Term Growth Plans - Newser
Should you wait for a breakout in 4D Molecular Therapeutics Inc.2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
Is 4D Molecular Therapeutics Inc. a candidate for recovery playSwing Trade & Safe Swing Trade Setups - Newser
Ranking 4D Molecular Therapeutics Inc. among high performing stocks via tools2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
How to track smart money flows in 4D Molecular Therapeutics Inc.July 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
Volume spikes in 4D Molecular Therapeutics Inc. stock – what they mean2025 Price Targets & Capital Protection Trade Alerts - Newser
What momentum shifts mean for 4D Molecular Therapeutics Inc.Long Setup & Weekly High Return Stock Opportunities - Newser
Detecting support and resistance levels for 4D Molecular Therapeutics Inc.Layoff News & Weekly Top Stock Performers List - Newser
Using Python tools to backtest 4D Molecular Therapeutics Inc. strategies2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
Is this a good reentry point in 4D Molecular Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
Candlestick signals on 4D Molecular Therapeutics Inc. stock today2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Multi asset correlation models including 4D Molecular Therapeutics Inc.Portfolio Profit Report & Verified Momentum Stock Alerts - Newser
4DMT Announces Leadership Expansion with Proven Late-Stage - GlobeNewswire
Former IZERVAY Developer Takes CMO Role: 4DMT Accelerates Phase 3 Wet AMD Gene Therapy Timeline - Stock Titan
Top chart patterns to watch in 4D Molecular Therapeutics Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Exit strategy if you’re trapped in 4D Molecular Therapeutics Inc.July 2025 Technicals & Smart Allocation Stock Tips - Newser
Real time social sentiment graph for 4D Molecular Therapeutics Inc.Trade Ideas & Safe Capital Preservation Plans - Newser
What is 4D Molecular Therapeutics Inc.’s book value per share2025 Market Overview & Weekly High Return Stock Forecasts - khodrobank.com
How do insiders feel about 4D Molecular Therapeutics Inc.July 2025 Opening Moves & Weekly High Return Opportunities - خودرو بانک
Can trapped investors hope for a rebound in 4D Molecular Therapeutics Inc.Insider Buying & Step-by-Step Swing Trade Plans - Newser
Applying chart zones and confluence areas to 4D Molecular Therapeutics Inc.Weekly Profit Report & Fast Gain Stock Tips - Newser
Published on: 2025-09-01 11:16:39 - Newser
4D Molecular Therapeutics Inc. stock chart pattern explainedGap Down & Real-Time Stock Entry Alerts - Newser
Should you avoid 4D Molecular Therapeutics Inc. stock right nowMarket Weekly Review & Risk Controlled Stock Pick Alerts - khodrobank.com
Published on: 2025-09-01 05:26:16 - Newser
Volatility clustering patterns for 4D Molecular Therapeutics Inc.2025 AllTime Highs & Daily Volume Surge Signals - Newser
Technical analysis overview for 4D Molecular Therapeutics Inc. stockTrade Volume Summary & High Accuracy Trade Signal Alerts - Newser
What institutional flow reveals about 4D Molecular Therapeutics Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser
Price momentum metrics for 4D Molecular Therapeutics Inc. explained2025 Key Highlights & Safe Entry Zone Tips - Newser
Will 4D Molecular Therapeutics Inc. stock go up soon2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Pattern recognition hints at 4D Molecular Therapeutics Inc. upsideJuly 2025 Institutional & Scalable Portfolio Growth Methods - Newser
4 D Molecular Therapeutics Inc Azioni (FDMT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4 D Molecular Therapeutics Inc Azioni (FDMT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bizily Scott | Chief Legal Officer |
Sep 16 '24 |
Sale |
16.33 |
500 |
8,165 |
6,781 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):